OverviewSuggest Edit

miRecule is a biotechnology company developing microRNA-based therapeutics. It offers a miRecule genomics-based drug discovery platform that integrates genomic sequencing, expression, and prognostic data from cancer patients with screening data of microRNA mimics to identify microRNA candidates for miR replacement therapy.

Latest Updates

Employees (est.) (Aug 2020)4
Cybersecurity ratingAMore

miRecule Financials and Metrics

Summary Metrics

Founding Date


miRecule total Funding

$75 k

miRecule latest funding size

$75 k

Time since last funding

10 months ago

miRecule investors

miRecule's latest funding round in October 2019 was reported to be $75 k. In total, miRecule has raised $75 k
Show all financial metrics

miRecule Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

miRecule Online and Social Media Presence

Embed Graph

miRecule Frequently Asked Questions

  • When was miRecule founded?

    miRecule was founded in 2016.

  • How many employees does miRecule have?

    miRecule has 4 employees.

  • Who are miRecule competitors?

    Competitors of miRecule include Imcyse, Blue Turtle Bio and Qulab.